Florida Cancer Specialists & Research Institute Welcomes Hematologist & Medical Oncologist Francis Matuszak, DO to Ocala Offices

News provided by

Florida Cancer Specialists & Research Institute

Jul 16, 2024, 10:00 ET

FORT MYERS, Fla., July 16, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that board-certified hematologist and medical oncologist Francis Matuszak, DO has joined the statewide practice. He is providing care to patients at the FCS Ocala Cancer Center, 4945 SW 49th Place, Ocala, FL 34474 and our FCS Ocala office, 1630 SE 18th St. Ste 602, Ocala FL 34471.

Florida Cancer Specialists & Research Institute welcomes Francis Matuszak, DO to its Ocala office locations. Dr. Matuszak will be providing care to patients at the Ocala Cancer Center and Ocala office.

Nathan H. Walcker, FCS chief executive officer, said, "We are delighted to welcome Dr. Matuszak to our team of top cancer experts in Marion County, where FCS is proud to provide a comprehensive range of services and the most advanced treatments that enable patients to achieve the best possible outcomes."

Dr. Matuszak received his medical degree from Lake Erie College of Osteopathic Medicine in Bradenton, Florida. He completed internal medicine residency training and a fellowship in hematology and oncology at Larkin Community Hospital in Miami and was named chief resident and chief fellow. He has specialized training as an HIV specialist from the American Association of HIV Medicine.

FCS President & Managing Physician Lucio Gordan, MD said, "Dr. Matuszak joins us with solid credentials and a commitment to supporting patients and their families through every step of their treatment journey."

To learn more about Dr. Matuszak, click here.

About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)

Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with FCS participation.* Recognized for our research, FCS is a recipient of the national Clinical Trials Participation Award presented by the American Society of Clinical Oncology (ASCO). FCS physicians, trained in prestigious medical schools and research institutes, are consistently ranked nationally as Top Doctors by U.S. News & World Report.

Celebrating its 40^th year in 2024, FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies genomic-based treatment and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.

*Prior to approval

SOURCE Florida Cancer Specialists & Research Institute